<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Hoyle, Brian</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Kuschyk, Jürgen</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Developments in Treatment of AHF</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2014</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2014-07-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">36-38</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses vagal stimulation as a treatment for chronic heart failure (CHF), an overview of research on baroreceptor stimulation, renal denervation in the treatment of HF, as well as the use of spinal cord stimulation to prevent ventricular tachycardia or fibrillation and sudden cardiac arrest.</style></abstract><number><style face="normal" font="default" size="100%">9</style></number><volume><style face="normal" font="default" size="100%">14</style></volume></record></records></xml>